Bexson Biomedical

Bexson Biomedical recently signed a deal with the Stevanato Group to develop a subcutaneous delivery system of ketamine. “SG EZ-be Pod,” a wearable device designed for administering subcutaneous drugs, would facilitate patient administration of medications outside of clinics...